Reports
Global Neglected Tropical Disease Treatment Market Growth: By Type: Antiparasitic Drugs, Antibacterial Drugs, Antiviral Drugs; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, Key Indicators for Demand, Key Indicators for Price; Value Chain Analysis; Competitive Landscape; 2024-2032
Global Neglected Tropical Disease Treatment Market Outlook
The global neglected tropical disease treatment market is expected to grow at a CAGR of 6% over the forecast period of 2024-2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
It is expected that the initiatives undertaken by several organisations worldwide to raise understanding and access to medicines for neglected tropical diseases will fuel the growth of the global neglected tropical disease treatment market. The growing prevalence of neglected tropical diseases has given rise to awareness-raising and the increased investment in the R&D sector to develop drugs for its treatment.
Market Segmentation
Neglected tropical diseases are a group of tropical infections, which are widespread in low-income communities, particularly in developing regions like Africa and Asia. These are caused by a variety of pathogens, including viruses, bacteria, protozoa, and helminths.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global neglected tropical disease treatment industry can be divided based on segments like types and regions.
The industry can be broadly categorised based on its types into:
- Antiparasitic Drugs
- Antibacterial Drugs
- Antiviral Drugs
The EMR report looks into the regional neglected tropical disease treatment markets like North America, Latin America, Europe, the Asia Pacific, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
Some of the root causes of neglected tropical diseases are the lack of proper hygiene, the lack of basic services such as clean water, and inadequate steps to prevent diseases. The governments across the nations are taking concerted measures to reduce the spread of neglected tropical diseases. India's Stop Dengue campaign aims to reduce dengue-related mortality and morbidity in the country by motivating people to adopt better health practices. In addition, organisations such as WHO are supporting the nation by providing free bed nets to reduce the number of malaria cases. These factors are expected to support the development of the global market for neglected tropical disease treatment in the future.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global neglected tropical disease treatment market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Bayer AG
- F. Hoffmann-La Roche Ltd
- GlaxoSmithKline plc
- Novartis AG
- Pfizer Inc.
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Region |
| Breakup by Type | Antiparasitic Drugs, Antibacterial Drugs, Antiviral Drugs |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Bayer AG, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Neglected Tropical Disease Treatment Market Analysis
8.1 Key Industry Highlights
8.2 Global Neglected Tropical Disease Treatment Historical Market (2018-2023)
8.3 Global Neglected Tropical Disease Treatment Market Forecast (2024-2032)
8.4 Global Neglected Tropical Disease Treatment Market by Type
8.4.1 Antiparasitic Drugs
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2023)
8.4.1.3 Forecast Trend (2024-2032)
8.4.2 Antibacterial Drugs
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2023)
8.4.2.3 Forecast Trend (2024-2032)
8.4.3 Antiviral Drugs
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2023)
8.4.3.3 Forecast Trend (2024-2032)
8.5 Global Neglected Tropical Disease Treatment Market by Region
8.5.1 North America
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2023)
8.5.1.3 Forecast Trend (2024-2032)
8.5.2 Europe
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2023)
8.5.2.3 Forecast Trend (2024-2032)
8.5.3 Asia Pacific
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2023)
8.5.3.3 Forecast Trend (2024-2032)
8.5.4 Latin America
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2018-2023)
8.5.4.3 Forecast Trend (2024-2032)
8.5.5 Middle East and Africa
8.5.5.1 Market Share
8.5.5.2 Historical Trend (2018-2023)
8.5.5.3 Forecast Trend (2024-2032)
9 North America Neglected Tropical Disease Treatment Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2023)
9.1.3 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2023)
9.2.3 Forecast Trend (2024-2032)
10 Europe Neglected Tropical Disease Treatment Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2023)
10.1.3 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2023)
10.2.3 Forecast Trend (2024-2032)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2023)
10.3.3 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2023)
10.4.3 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Neglected Tropical Disease Treatment Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2023)
11.1.3 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2023)
11.2.3 Forecast Trend (2024-2032)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2023)
11.3.3 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2023)
11.4.3 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2018-2023)
11.5.3 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Neglected Tropical Disease Treatment Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2023)
12.1.3 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2018-2023)
12.2.3 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2018-2023)
12.3.3 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Neglected Tropical Disease Treatment Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2023)
13.1.3 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2023)
13.2.3 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2018-2023)
13.3.3 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2018-2023)
13.4.3 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Bayer AG
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 F. Hoffmann-La Roche Ltd
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 GlaxoSmithKline plc
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Novartis AG
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 Pfizer Inc.
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
16.2.6 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Neglected Tropical Disease Treatment Market: Key Industry Highlights, 2018 and 2032
2. Global Neglected Tropical Disease Treatment Historical Market: Breakup by Type (USD Billion), 2018-2023
3. Global Neglected Tropical Disease Treatment Market Forecast: Breakup by Type (USD Billion), 2024-2032
4. Global Neglected Tropical Disease Treatment Historical Market: Breakup by Region (USD Billion), 2018-2023
5. Global Neglected Tropical Disease Treatment Market Forecast: Breakup by Region (USD Billion), 2024-2032
6. North America Neglected Tropical Disease Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
7. North America Neglected Tropical Disease Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
8. Europe Neglected Tropical Disease Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
9. Europe Neglected Tropical Disease Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
10. Asia Pacific Neglected Tropical Disease Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
11. Asia Pacific Neglected Tropical Disease Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
12. Latin America Neglected Tropical Disease Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
13. Latin America Neglected Tropical Disease Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
14. Middle East and Africa Neglected Tropical Disease Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
15. Middle East and Africa Neglected Tropical Disease Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
16. Global Neglected Tropical Disease Treatment Market Structure
Key Questions Answered in the Report
The market is projected to grow at a CAGR of 6% between 2023 and 2032.
The major drivers of the industry include government intervention for hygiene and monetary and non-monetary help from major international non-governmental organisations like the WHO.
The rising awareness-raising and the increased investment in the R&D sector is expected to be a key trend guiding the growth of the industry.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The types of neglected tropical disease treatment available are antiparasitic drugs, antibacterial drugs, and antiviral drugs.
The leading players in this market are Bayer AG, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Novartis AG, and Pfizer Inc., amongst others.
Analyst Review
The global neglected tropical disease treatment market was driven by government intervention for hygiene and monetary and non-monetary help from major international non-governmental organisations like the WHO. Aided by the rising awareness-raising and the increased investment in the R&D sector, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 6%.
EMR’s meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. The major regional markets for xx are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. Based on the type, the neglected tropical disease treatment market can be segmented into antiparasitic drugs, antibacterial drugs and antiviral drugs. The key players in the above industry include Bayer AG, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Novartis AG, and Pfizer Inc., amongst others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$2799
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER